STSA - Satsuma Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

STSA is currently covered by 3 analysts with an average potential upside of $5.08 (72.44%) from yesterday's end of day stock price of $. Satsuma Pharmaceuticals activity chart has currently 13 price targets and 18 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44% with an average time for these price targets to be met of 101 days.

Highest price target for STSA is $6, Lowest price target is $1, average price target is $3.5.

Most recent stock forecast was given by OREN LIVNAT from HCWAINWRIGHT on 18-Apr-2023. First documented stock forecast 02-Mar-2020.

Split History since 2000:

9/1/05 3 for 2

5/6/04 11 for 10

5/1/03 11 for 10

5/1/02 11 for 10

11/6/01 11 for 10

11/2/00 11 for 10

Best performing analysts who are covering STSA - Satsuma Pharmaceuticals:

Evan Seigerman Vamil Divan Marc Goodman Oren Livnat Stephen Kim

Currently, out of the existing stock ratings of STSA - 4 which are a Buy (66.67%), 2 which are a Hold (33.33%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

3

7 months 21 days ago

1/5 (20%)

$5.33 (184.44%)

141

Hold

14

1 years 23 days ago

0/1 (0%)

$8.01 (133.72%)

Hold

1 years 24 days ago

4/4 (100%)

$0.29 (3.35%)

152

Buy

1 years 24 days ago

0/1 (0%)

$11.25 (47.37%)

Hold

3.5

2 years 7 months 13 days ago

3/3 (100%)

$0.51 (-6.67%)

212

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STSA (Satsuma Pharmaceuticals) average time for price targets to be met?

On average it took 101 days on average for the stock forecasts to be realized with a an average price target met ratio 44

Which analyst has the current highest performing score on STSA (Satsuma Pharmaceuticals) with a proven track record?

EVAN SEIGERMAN

Which analyst has the current lower performing score on STSA (Satsuma Pharmaceuticals) with a proven track record?

STEPHEN KIM

Which analyst has the most public recommendations on STSA (Satsuma Pharmaceuticals)?

Evan Seigerman works at BMO and has 18 price targets and 14 ratings on STSA

Which analyst is the currently most bullish on STSA (Satsuma Pharmaceuticals)?

Stephen Kim with highest potential upside - $0

Which analyst is the currently most reserved on STSA (Satsuma Pharmaceuticals)?

Evan Seigerman with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart